Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 12 min ago
PreprintCC BYbioRxiv

Modulation of planarian seizure-like activity via antiseizure medications

  1. 1Swarthmore College

Abstract

Acute chemical exposure to organophosphorus compounds (OPs) arising from terrorist attacks or accidental poisonings pose a serious threat to human health. Acetylcholinesterase inhibition due to acute OP exposure causes a cholinergic crisis, manifested as increased secretions, respiratory distress, loss of consciousness, seizures, and ultimately death if left untreated. Benzodiazepines, such as midazolam, are currently used to stop OP-induced seizures, but must be administered within minutes after exposure to be effective. This makes midazolam impractical for large-scale civilian emergencies. Thus, there is a need to identify novel antiseizure medications (ASMs) that are equally effective even when administered later. It has been challenging to identify such compounds with traditional mammalian testing; high throughput screening assays that can quickly and cost-effectively evaluate many candidates for their potential as an ASM are needed. Planarians are aquatic invertebrates that are suitable organismal models for OP neurotoxicity studies due to the conservation of OP targets and their ability to metabolize OPs. Here, we built on our prior work that introduced a computational image analysis pipeline to quantify planarian seizure-like activity (pSLA) in two planarian species (Dugesia japonica and Girardia dorotocephala). We previously used this approach to characterize pSLA following acute exposure (up to 30 minutes) to seizurogenic compounds. In the present study, we asked whether pSLA induced by the OP pesticide parathion, pentylenetetrazole, or NMDA could be rescued by co-exposure to four ASMs: midazolam, topiramate, MK-801, and carbamazepine. All tested ASMs were effective at reducing parathion-induced pSLA in one planarian species. However, ASM responses varied substantially across proconvulsants and planarian species. Defining the molecular mechanisms underlying pSLA will be essential for establishing planarians as a reliable model for ASM discovery.

Related

  1. Pharmacokinetic changes and seizure outcomes in pregnant women taking second-generation antiseizure medications
    Nanya Hao, Xiaoli Yi, Renjie Zhao +3
    Acta EpileptologicaPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsPMC
  2. Male Reproductive Disorders Associated with Antiseizure Medications: Evidence from Meta-Analysis and FAERS Pharmacovigilance Study
    Heejin Na, Boyoon Choi, Se-Hoon Oh +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Antiseizure medication-induced changes in serum ephrin-B2 and their association with treatment response in adults with generalised seizure disorders in Northern India: protocol for a prospective observational cohort study
    Mangesh Bankar, Archana Verma, Ankit Gupta
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossrefPMC
  4. From first seizure to specific antiseizure medication in Dravet syndrome: Quantifying delays in the DS ' coverED study
    Loucas Christodoulou, Maria Ballarà Petitbò, Sergio Aguilera Albesa +7
    Epilepsia OpenPeer-reviewedCC BY-NC-ND 4.0Full text1 citedPsychiatry & mental healthHAL
  5. CYP2C9 Pharmacogenetic Variants and Adverse Drug Reactions to Antiseizure Medications: An Exploratory Analysis in the Venezuelan Andes.
    Alexis Morales-Ortiz, Luis Abel Quiñones, Sol Betzabeth Rondón-Simancas +19
    International journal of molecular sciencesPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
BibTeX
@misc{ireland2026modulation,
  title = {{Modulation of planarian seizure-like activity via antiseizure medications}},
  author = {D. Ireland and E. Bormann and E. Coffinas and C. Rabeler and E.-M. S. Collins},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.23.761305},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.23.761305v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Modulation of planarian seizure-like activity via antiseizure medications
AU  - D. Ireland
AU  - E. Bormann
AU  - E. Coffinas
AU  - C. Rabeler
AU  - E.-M. S. Collins
PY  - 2026
DA  - 2026/10/23
PB  - bioRxiv
DO  - 10.64898/2026.10.23.761305
UR  - https://www.biorxiv.org/content/10.64898/2026.10.23.761305v1
AB  - Acute chemical exposure to organophosphorus compounds (OPs) arising from terrorist attacks or accidental poisonings pose a serious threat to human health. Acetylcholinesterase inhibition due to acute OP exposure causes a cholinergic crisis, manifested as increased secretions, respiratory distress, loss of consciousness, seizures, and ultimately death if left untreated. Benzodiazepines, such as midazolam, are currently used to stop OP-induced seizures, but must be administered within minutes after exposure to be effective. This makes midazolam impractical for large-scale civilian emergencies. Thus, there is a need to identify novel antiseizure medications (ASMs) that are equally effective even when administered later. It has been challenging to identify such compounds with traditional mammalian testing; high throughput screening assays that can quickly and cost-effectively evaluate many candidates for their potential as an ASM are needed. Planarians are aquatic invertebrates that are suitable organismal models for OP neurotoxicity studies due to the conservation of OP targets and their ability to metabolize OPs. Here, we built on our prior work that introduced a computational image analysis pipeline to quantify planarian seizure-like activity (pSLA) in two planarian species (Dugesia japonica and Girardia dorotocephala). We previously used this approach to characterize pSLA following acute exposure (up to 30 minutes) to seizurogenic compounds. In the present study, we asked whether pSLA induced by the OP pesticide parathion, pentylenetetrazole, or NMDA could be rescued by co-exposure to four ASMs: midazolam, topiramate, MK-801, and carbamazepine. All tested ASMs were effective at reducing parathion-induced pSLA in one planarian species. However, ASM responses varied substantially across proconvulsants and planarian species. Defining the molecular mechanisms underlying pSLA will be essential for establishing planarians as a reliable model for ASM discovery.
ER  -